TABLE 1 .
Serotype | Serogroup | No. of reported laboratory-confirmed human clinical cases in 2011a | Proportion of S-CDT-positive isolatesb |
|
---|---|---|---|---|
% | No. positive/total | |||
Enteritidis | D1 | 7,553 | 0 | 0/50 |
Typhimuriumc | B | 6,131 | 0 | 0/50 |
Newport | C2−C3 | 5,211 | 0 | 0/50 |
Javiana | D1 | 2,937 | 100 | 50/50 |
I 4, [5], 12:i: − | B | 1,339 | 0 | 0/50 |
Montevideo | C1 | 1,196 | 100 | 50/50 |
Heidelberg | B | 1,103 | 0 | 0/50 |
München | C2−C3 | 984 | 0 | 0/48 |
Infantis | C1 | 910 | 0 | 0/50 |
Braenderup | C1 | 739 | 0 | 0/50 |
Oranienburg | C1 | 721 | 100 | 50/50 |
Saint Paul | B | 709 | 0 | 0/50 |
Mississippi | G | 549 | 50 | 4/8 |
Thompson | C1 | 536 | 0 | 0/50 |
Agona | B | 505 | 0 | 0/50 |
Bareilly | C1 | 429 | 0 | 0/22 |
Berta | D1 | 321 | 0 | 0/20 |
Anatum | E1 | 282 | 0 | 0/50 |
Hartford | C1 | 241 | 0 | 0/18 |
I 13,23:b: − | G | 218 | 0 | 0/1 |
Hadar | C2−C3 | 205 | 0 | 0/47 |
Reported laboratory-confirmed human clinical cases in 2011 according to the CDC’s National Salmonella Surveillance report of 2011.
The presence of all S-CDT components (pltA, pltB, and cdtB) as determined by PCR amplification and the proportion of S-CDT-positive strains tested per serotype.
Serotype Typhimurium includes Typhimurium variant O:5−.